Xvivo Perfusion AB (publ) (XVIPF)

Market Cap	638.12M -47.4%
Revenue (ttm)	88.11M -1.2%
Net Income	2.73M -85.4%
EPS	0.09 -85.3%
Shares Out	n/a
PE Ratio	233.74
Forward PE	44.52
Dividend	n/a
Ex-Dividend Date	n/a

Volume	519
Average Volume	364
Open	23.79
Previous Close	23.85
Day's Range	23.52 - 23.79
52-Week Range	16.98 - 44.00
Beta	1.89
RSI	51.75
Earnings Date	Jan 27, 2026

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 198
• Stock Exchange: OTCMKTS
• Ticker Symbol: XVIPF

Financial Performance

In 2025, Xvivo Perfusion AB's revenue was 812.17 million, a decrease of -1.25% compared to the previous year's 822.42 million. Earnings were 25.16 million, a decrease of -85.39%.

Financial numbers in SEK